| 000 | 01623 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515104656.0 | ||
| 264 | 0 | _c20080613 | |
| 008 | 200806s 0 0 eng d | ||
| 022 | _a1473-4877 | ||
| 024 | 7 |
_a10.1185/030079908X260952 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSharma, S K | |
| 245 | 0 | 0 |
_aBiphasic insulin aspart 30 treatment in patients with type 2 diabetes poorly controlled on prior diabetes treatment: results from the PRESENT study. _h[electronic resource] |
| 260 |
_bCurrent medical research and opinion _cMar 2008 |
||
| 300 |
_a645-52 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBiphasic Insulins |
| 650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xmetabolism |
| 650 | 0 | 4 | _aGlycemic Index |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 |
_aInsulin _xadverse effects |
| 650 | 0 | 4 | _aInsulin Aspart |
| 650 | 0 | 4 | _aInsulin, Isophane |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPostprandial Period |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aTreatment Failure |
| 700 | 1 | _aAl-Mustafa, M | |
| 700 | 1 | _aOh, S J | |
| 700 | 1 | _aAzar, S T | |
| 700 | 1 | _aShestakova, M | |
| 700 | 1 | _aGuler, S | |
| 700 | 1 | _aVaz, J A | |
| 773 | 0 |
_tCurrent medical research and opinion _gvol. 24 _gno. 3 _gp. 645-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1185/030079908X260952 _zAvailable from publisher's website |
| 999 |
_c17722810 _d17722810 |
||